rs140578009

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001875.5(CPS1):​c.4126G>A​(p.Gly1376Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0136 in 1,613,610 control chromosomes in the GnomAD database, including 205 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G1376G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.013 ( 31 hom., cov: 33)
Exomes 𝑓: 0.014 ( 174 hom. )

Consequence

CPS1
NM_001875.5 missense

Scores

5
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 4.38

Publications

24 publications found
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]
CPS1 Gene-Disease associations (from GenCC):
  • carbamoyl phosphate synthetase I deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0067127645).
BP6
Variant 2-210674926-G-A is Benign according to our data. Variant chr2-210674926-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 258484.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0127 (1939/152234) while in subpopulation AMR AF = 0.0158 (242/15282). AF 95% confidence interval is 0.0148. There are 31 homozygotes in GnomAd4. There are 984 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 31 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001875.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
NM_001875.5
MANE Select
c.4126G>Ap.Gly1376Ser
missense
Exon 35 of 38NP_001866.2
CPS1
NM_001369256.1
c.4159G>Ap.Gly1387Ser
missense
Exon 36 of 39NP_001356185.1
CPS1
NM_001122633.3
c.4126G>Ap.Gly1376Ser
missense
Exon 36 of 39NP_001116105.2P31327-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
ENST00000233072.10
TSL:1 MANE Select
c.4126G>Ap.Gly1376Ser
missense
Exon 35 of 38ENSP00000233072.5P31327-1
CPS1
ENST00000430249.7
TSL:1
c.4144G>Ap.Gly1382Ser
missense
Exon 36 of 39ENSP00000402608.2P31327-3
CPS1
ENST00000451903.3
TSL:1
c.2773G>Ap.Gly925Ser
missense
Exon 25 of 28ENSP00000406136.2P31327-2

Frequencies

GnomAD3 genomes
AF:
0.0127
AC:
1936
AN:
152116
Hom.:
31
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00292
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0159
Gnomad ASJ
AF:
0.0354
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00642
Gnomad FIN
AF:
0.0293
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0156
Gnomad OTH
AF:
0.0172
GnomAD2 exomes
AF:
0.0131
AC:
3283
AN:
251254
AF XY:
0.0132
show subpopulations
Gnomad AFR exome
AF:
0.00258
Gnomad AMR exome
AF:
0.0109
Gnomad ASJ exome
AF:
0.0299
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0313
Gnomad NFE exome
AF:
0.0141
Gnomad OTH exome
AF:
0.0245
GnomAD4 exome
AF:
0.0137
AC:
20051
AN:
1461376
Hom.:
174
Cov.:
29
AF XY:
0.0136
AC XY:
9875
AN XY:
727016
show subpopulations
African (AFR)
AF:
0.00263
AC:
88
AN:
33472
American (AMR)
AF:
0.0125
AC:
561
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0304
AC:
795
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.00473
AC:
408
AN:
86246
European-Finnish (FIN)
AF:
0.0315
AC:
1683
AN:
53402
Middle Eastern (MID)
AF:
0.0361
AC:
208
AN:
5758
European-Non Finnish (NFE)
AF:
0.0139
AC:
15419
AN:
1111612
Other (OTH)
AF:
0.0147
AC:
889
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
895
1789
2684
3578
4473
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
570
1140
1710
2280
2850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0127
AC:
1939
AN:
152234
Hom.:
31
Cov.:
33
AF XY:
0.0132
AC XY:
984
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00291
AC:
121
AN:
41542
American (AMR)
AF:
0.0158
AC:
242
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0354
AC:
123
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5182
South Asian (SAS)
AF:
0.00664
AC:
32
AN:
4822
European-Finnish (FIN)
AF:
0.0293
AC:
311
AN:
10604
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0156
AC:
1063
AN:
68012
Other (OTH)
AF:
0.0170
AC:
36
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
99
197
296
394
493
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0139
Hom.:
33
Bravo
AF:
0.0108
TwinsUK
AF:
0.0138
AC:
51
ALSPAC
AF:
0.0153
AC:
59
ESP6500AA
AF:
0.00454
AC:
20
ESP6500EA
AF:
0.0164
AC:
141
ExAC
AF:
0.0118
AC:
1430
EpiCase
AF:
0.0175
EpiControl
AF:
0.0176

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
Congenital hyperammonemia, type I (4)
-
-
2
not specified (2)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.20
T
Eigen
Benign
0.036
Eigen_PC
Uncertain
0.25
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.88
D
MetaRNN
Benign
0.0067
T
MetaSVM
Benign
-0.64
T
MutationAssessor
Benign
0.57
N
PhyloP100
4.4
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
0.64
N
REVEL
Benign
0.28
Sift
Benign
0.19
T
Sift4G
Benign
0.24
T
Polyphen
0.0070
B
Vest4
0.074
MPC
0.23
ClinPred
0.0090
T
GERP RS
5.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.40
gMVP
0.51
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140578009; hg19: chr2-211539650; COSMIC: COSV51818882; API